The Drug Controller General of India has recently approved oral anti Kala-azar drug "Miltefosine" for treatment of Kala-azar patients.
The clinical trials of Miltefosine - oral drug have been conducted by Indian Council of Medical Research, New Delhi. Based on the results of clinical trials, the Expert Committee of the Directorate of Health Services has recommended introduction of Miltefosine as first line of treatment.
The Government of India has already decided to introduce the drug in 10 Kala-azar endemic districts in the country and procurement of drug is under way.
This information was given in the Lok Sabha today by Smt. Panabaka Lakshmi, Minister of State in the Ministry of Health and Family Welfare in a written reply to a question by Shri Braja Kishore Tripathy.